No Data
Johnson & Johnson Declares $1.24 Quarterly Dividend; 3.4% Yield
Press Release: Johnson & Johnson Announces Quarterly Dividend for First Quarter 2025
Express News | Johnson & Johnson Announces Quarterly Dividend for First Quarter 2025
Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?
Johnson & Johnson (JNJ.US) has applied for the market launch of its innovative compound drug "Mexitentan Tadalafil Tablets" in China for the treatment of pulmonary arterial hypertension.
The CDE website shows that Johnson & Johnson (JNJ.US) has submitted an application for the innovative compound drug "Maqitengtan Tadalafil Tablets" to be marketed domestically for the treatment of pulmonary arterial hypertension (PAH).
Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note
loading...
loading...
loading...
No Data
105251507 : i thought u got lot of position??..what happen to soxl call?
ひな☆彡 SOXL(Bull) OP 105251507 : Just shared the stocks that I think will grow… I still have massive long call
ひな☆彡 SOXL(Bull) OP 105251507 : There you go, I did not want to tag all the stock because the title is which individual stock will grow
ひな☆彡 SOXL(Bull) OP : My entire position is on this post
Weekly Report W3 December
晴瓦林 : I believe the most reliable one are $SPDR Gold ETF (GLD.US)$ or $ProShares Ultra Gold (UGL.US)$
View more comments...